Telerehabilitation Decision Support System: Pilot Testing Protocol

Summary

This study follows the successfully completed HOLOBalance project which was funded by the EU Horizon 2020 scheme. TheHOLOBalance platform delivers exercises demonstrated via a hologram of the physiotherapist and corrected in real time by the hologram prompts based on performance monitoring via sensors. Further information is available at: https://holobalance.eu/. HOLOBalance was developed as a comprehensive rehabilitation protocol for individualised remote (tele)rehabilitation balance physiotherapy programme. It includes different multisensory balance and gait exercises, physical activity and memory training and exergames (video games which are also exercises) to improve balance function in older adults. The system can thus assess and remotely monitor how users are performing the exercises.

This pilot testing of a multisite randomised control trial (TeleRehab DSS, short for TeleRehabilitation Decision Support System) aims to investigating the usability and feasibility among a smaller sample population at each clinical site, identifying any technical bugs, and/or clinical procedural flaws to be remedied before delivery of the full-scale RCT.

Conditions

• Stroke
• Mild Cognitive Impairment (MCI)
• Vestibular Disease
• Long Covid-19

Interventions

DEVICE

TeleRehab DSS Pilot Test

Participants will perform an individualised multisensory balance rehabilitation program via augmented reality, while wearing motion sensors. The program will consist of multisensory balance exercises, cognitive games, and exergames. All participants will perform 2 sessions per week, carried in at each clinical site, over the course of 3-week.s

Sponsors & Collaborators

• National and Kapodistrian University of Athens

  collaborator OTHER

• University Medical Center Freiburg

  collaborator OTHER

• King Chulalongkorn Memorial Hospital

  collaborator OTHER

• Secretaria Regional de Saúde e Proteção Civil da Região Autónoma da Madeira

  collaborator UNKNOWN

• Institute of Communications and Computer Systems, Athens, Greece

  collaborator OTHER

• University of Ioannina

  collaborator OTHER

• Vilabs

  collaborator UNKNOWN

• BioIRC

  collaborator UNKNOWN

• Activage

  collaborator UNKNOWN

• Institue De Desenvolvimento De Novas Technologiassociacao

  collaborator UNKNOWN

• Quantitas SRL

  collaborator UNKNOWN

• Instituto para o Desenvolvimento e Inovação

  collaborator UNKNOWN

• BRIDG

  collaborator UNKNOWN

• University College, London

  lead OTHER

Principal Investigators

• Doris-Eva Bamiou, PhD · University College, London

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-07-25

Primary Completion

2025-08-18

Completion

2025-08-29

Countries

• Germany
• Greece
• Portugal
• Thailand
• United Kingdom

Study Locations